REG - Iconic Labs PLC - Results of AGM
RNS Number : 3411KIconic Labs PLC04 January 2021
Iconic Labs Plc ("Iconic Labs" or the "Company")
Results of AGM
Iconic Labs plc (AIM: ICON), a multi-divisional new media and technology business, advises that it held its Annual General Meeting ("AGM") on 31st December 2020.
All resolutions were duly passed on a poll vote, with the exception of resolutions 8 and 9.
Details of the proxy voting are shown in the table below.
Ordinary resolutions
Votes For
%
Votes Against
%
Votes Total
Votes Withheld
1. Annual report and accounts
2,438,131,706
72.2%
940,030,000
27.8%
3,378,161,706
-
2. Directors' remuneration report
2,381,589,539
70.5%
979,288,670
29.0%
3,378,161,706
17,283,497
3. Reappointment of directors (Liam Harrington)
2,375,239,672
70.3%
1,002,905,084
29.7%
3,378,161,706
16,950
4. Reappointment of directors (Katharine Lewis)
2,395,759,198
70.9%
982,385,558
29.1%
3,378,161,706
16,950
5. Re-appointment of auditors
2,432,434,510
72.0%
945,680,246
28.0%
3,378,161,706
46,950
6. Remuneration of auditors
2,416,935,877
71.5%
961,225,829
28.5%
3,378,161,706
-
7. Allotment of Shares
1,698,250,476
50.3%
1,679,911,230
49.7%
3,378,161,706
-
Special Resolutions
8. Empowering the directors' to disapply statutory pre-emption rights
1,697,355,094
50.2%
1,680,806,612
49.8%
3,378,161,706
-
9. Purchase by the Company of its own shares
2,409,770,834
71.3%
968,390,872
28.7%
3,378,161,706
-
The full text of each of the resolutions is set out in the Notice of AGM, available on the Company's website (www.iconiclabs.co.uk)
Market Abuse Regulation (MAR) Disclosure - Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
**ENDS**
For further information, please visit the Company's website www.iconiclabs.co.uk or contact:
Damon Heath
Shard Capital Partners LLP
Tel: +44 (0) 20 7186 9950
Iconic Labs ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDRAGTBBRTMTMJBJM
Recent news on Iconic Labs
See all newsREG - Iconic Labs PLC - Interim Results
AnnouncementREG - Iconic Labs PLC - Heads of Terms Signed
AnnouncementREG - Iconic Labs PLC - Suspension of Trading
AnnouncementREG - Iconic Labs PLC - Total Voting Rights
AnnouncementREG - Official List - Suspension - Iconic Labs Plc
Announcement